Acquisition Announced

Danaher acquisition of Masimo

US$9.9bn enterprise value

Announced 17 Feb 2026 · NASDAQ: MASI · US$180.00 cash per share · 38% premium

Advisers

Masimo

Target

Communications
Fairness opinion

Danaher

Acquirer

Financial adviser
Legal adviser

Investor

Legal adviser
Target
Masimo
Acquirer
Danaher
Target based in
United States
Buyer based in
United States
Sector
Medtech
Tags
Medtech, Diagnostics

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.